GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Globus Medical Inc (MEX:GMED) » Definitions » Cyclically Adjusted Revenue per Share

Globus Medical (MEX:GMED) Cyclically Adjusted Revenue per Share : MXN175.70 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Globus Medical Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Globus Medical's adjusted revenue per share for the three months ended in Mar. 2024 was MXN74.383. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN175.70 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Globus Medical's average Cyclically Adjusted Revenue Growth Rate was 14.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Globus Medical was 12.90% per year. The lowest was 12.90% per year. And the median was 12.90% per year.

As of today (2024-06-22), Globus Medical's current stock price is MXN990.00. Globus Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was MXN175.70. Globus Medical's Cyclically Adjusted PS Ratio of today is 5.63.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Globus Medical was 12.34. The lowest was 5.01. And the median was 8.55.


Globus Medical Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Globus Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Globus Medical Cyclically Adjusted Revenue per Share Chart

Globus Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 105.85 160.65 151.93 168.31

Globus Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 205.65 139.58 172.48 168.31 175.70

Competitive Comparison of Globus Medical's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Globus Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Globus Medical's Cyclically Adjusted PS Ratio falls into.



Globus Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Globus Medical's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=74.383/131.7762*131.7762
=74.383

Current CPI (Mar. 2024) = 131.7762.

Globus Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 15.427 100.560 20.216
201409 16.565 100.428 21.736
201412 19.853 99.070 26.407
201503 20.920 99.621 27.672
201506 21.819 100.684 28.557
201509 24.084 100.392 31.613
201512 25.483 99.792 33.650
201603 24.896 100.470 32.653
201606 26.369 101.688 34.171
201609 27.182 101.861 35.165
201612 32.381 101.863 41.890
201703 30.199 102.862 38.688
201706 28.160 103.349 35.906
201709 28.144 104.136 35.614
201712 35.018 104.011 44.366
201803 31.530 105.290 39.462
201806 33.562 106.317 41.599
201809 31.095 106.507 38.473
201812 37.927 105.998 47.151
201903 35.009 107.251 43.015
201906 36.787 108.070 44.857
201909 37.940 108.329 46.152
201912 38.781 108.420 47.135
202003 43.748 108.902 52.937
202006 35.252 108.767 42.709
202009 47.508 109.815 57.009
202012 45.789 109.897 54.905
202103 45.373 111.754 53.502
202106 48.289 114.631 55.511
202109 45.237 115.734 51.507
202112 49.221 117.630 55.141
202203 44.106 121.301 47.915
202206 51.554 125.017 54.341
202209 50.408 125.227 53.044
202212 52.362 125.222 55.103
202303 48.801 127.348 50.498
202306 49.119 128.729 50.282
202309 57.986 129.860 58.842
202312 75.801 129.419 77.181
202403 74.383 131.776 74.383

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Globus Medical  (MEX:GMED) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Globus Medical's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=990.00/175.7
=5.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Globus Medical was 12.34. The lowest was 5.01. And the median was 8.55.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Globus Medical Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Globus Medical's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Globus Medical (MEX:GMED) Business Description

Traded in Other Exchanges
Address
2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.